Company intelligence / Profile preview

GMS Biotech

Tucson, Arizona, United Statesgmsbiotech.com ↗

Ownership: Private
Employees: ~15
Development stage: Other

Overview

GMS Biotech is a biotechnology company focused on the development and commercialization of advanced microarray technologies for molecular diagnostics. The company's proprietary platform utilizes a unique surface chemistry that enables rapid, high-sensitivity detection of DNA and RNA targets. Their primary applications include Human Leukocyte Antigen (HLA) typing for transplantation and the detection of various infectious pathogens. By simplifying the microarray workflow, GMS Biotech aims to bring high-complexity molecular testing closer to the point of care. The company provides both hardware systems and specialized assay kits to clinical and research institutions worldwide.

Therapeutic areas: Infectious DiseasesImmunologyRare Diseases
Modalities: DeviceMicroarray
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on GMS Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GMS Biotech.

Explore the full profile